Optimal reversal of vitamin K antagonists
- 31 December 2007
- journal article
- editorial
- Published by Elsevier in Thrombosis Research
- Vol. 119 (1) , 15-16
- https://doi.org/10.1016/j.thromres.2005.10.003
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: An open, prospective randomized controlled trialThrombosis Research, 2006
- Hemorrhagic Complications of Anticoagulant TreatmentChest, 2004
- Care of Patients Receiving Long-Term Anticoagulant TherapyNew England Journal of Medicine, 2003
- Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complicationThrombosis Research, 2002
- Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patientsBritish Journal of Haematology, 2002
- Beriplex P/N reverses severe warfarin‐induced overanticoagulation immediately and completely in patients presenting with major bleedingBritish Journal of Haematology, 2001
- Management and Prognostic Features of Intracerebral Hemorrhage During Anticoagulant Therapy: A Swedish Multicenter StudyStroke, 2001
- Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trialThe Lancet, 2000
- Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergenciesBritish Journal Of Neurosurgery, 2000
- Emergency reversal of anticoagulation after intracerebral hemorrhage.Stroke, 1992